DK2074221T3 - Forbedrede fremgangsmåder til separation af streptococcus pneumoniae type 3 polysakkarider - Google Patents

Forbedrede fremgangsmåder til separation af streptococcus pneumoniae type 3 polysakkarider

Info

Publication number: DK2074221T3
Authority: DK; Denmark
Prior art keywords: lysate; methods; precipitation; cause; aggregation
Prior art date: 2006-10-10

Application number

DK07843999.9T

Other languages

English (en)

Inventor

Brian Douglas Bahler

Erik Heller Hughes

Tsu-Shun Lee

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-10

Filing date

2007-10-09

Publication date

2010-09-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39156240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2074221(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-10-09 Application filed by Wyeth Llc filed Critical Wyeth Llc

2010-09-06 Application granted granted Critical

2010-09-06 Publication of DK2074221T3 publication Critical patent/DK2074221T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Epidemiology (AREA)
Materials Engineering (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Polymers & Plastics (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Separation Using Semi-Permeable Membranes (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Compounds Of Unknown Constitution (AREA)

DK07843999.9T 2006-10-10 2007-10-09 Forbedrede fremgangsmåder til separation af streptococcus pneumoniae type 3 polysakkarider DK2074221T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US85066506P	2006-10-10	2006-10-10
PCT/US2007/080768 WO2008045852A2 (en)	2006-10-10	2007-10-09	Purification of streptococcus pneumoniae type 3 polysaccharides

Publications (1)

Publication Number	Publication Date
DK2074221T3 true DK2074221T3 (da)	2010-09-06

Family

ID=39156240

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07843999.9T DK2074221T3 (da)	2006-10-10	2007-10-09	Forbedrede fremgangsmåder til separation af streptococcus pneumoniae type 3 polysakkarider

Country Status (18)

Country	Link
US (1)	US7659090B2 (da)
JP (1)	JP5260531B2 (da)
KR (1)	KR101467002B1 (da)
CN (2)	CN102648979B (da)
AT (1)	ATE473289T1 (da)
AU (1)	AU2007307800C1 (da)
BR (2)	BRPI0717834B8 (da)
CA (1)	CA2665169C (da)
CL (1)	CL2007002909A1 (da)
DE (1)	DE602007007642D1 (da)
DK (1)	DK2074221T3 (da)
ES (1)	ES2346929T3 (da)
IL (2)	IL197782A (da)
MX (1)	MX2009003730A (da)
PT (1)	PT2074221E (da)
RU (1)	RU2460539C2 (da)
WO (1)	WO2008045852A2 (da)
ZA (1)	ZA200902502B (da)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0822634D0 (en)	2008-12-11	2009-01-21	Novartis Ag	Meningitis vaccines
ES2749952T3 (es)	2008-12-18	2020-03-24	Wyeth Llc	Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
DK2379734T3 (da) *	2008-12-18	2018-04-23	Wyeth Llc	Fremgangsmåde til at styre molekylvægten af polysaccharid af streptococcus pneumoniae serotype 19A
US20120064103A1 (en)	2009-03-24	2012-03-15	Novartis Ag	Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
PL2411048T3 (pl)	2009-03-24	2020-11-16	Glaxosmithkline Biologicals Sa	Adjuwantowe meningokokowe białko wiążące czynnik h
WO2010125480A1 (en)	2009-04-30	2010-11-04	Coley Pharmaceutical Group, Inc.	Pneumococcal vaccine and uses thereof
CA2803239A1 (en)	2010-06-25	2011-12-29	Novartis Ag	Combinations of meningococcal factor h binding proteins
CN102094053B (zh) *	2010-11-26	2013-01-16	兰州生物制品研究所有限责任公司	肺炎链球菌c多糖的纯化方法
US20140112950A1 (en)	2011-03-02	2014-04-24	Manmohan Singh	Combination vaccines with lower doses of antigen and/or adjuvant
AU2011384634A1 (en)	2011-12-29	2014-06-19	Novartis Ag	Adjuvanted combinations of meningococcal factor H binding proteins
CN104519910B (zh)	2012-03-07	2017-05-03	诺华股份有限公司	肺炎链球菌抗原的含佐剂制剂
JP2015509963A (ja)	2012-03-08	2015-04-02	ノバルティスアーゲー	Ｔｌｒ４アゴニストを含む混合ワクチン
EP2892553A1 (en)	2012-09-06	2015-07-15	Novartis AG	Combination vaccines with serogroup b meningococcus and d/t/p
MX363051B (es) *	2012-09-07	2019-03-06	Sk Bioscience Co Ltd	Metodo para producir un polisacárido capsular con un serotipo de neumococo.
US20150320852A1 (en)	2012-12-18	2015-11-12	Glaxosmithkline Biologicals Sa	Conjugates for protecting against diphtheria and/or tetanus
US11160855B2 (en)	2014-01-21	2021-11-02	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
KR20210032013A (ko)	2014-01-21	2021-03-23	화이자 인코포레이티드	스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
SI3096783T1 (sl)	2014-01-21	2021-09-30	Pfizer Inc.	Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati
PT3096785T (pt)	2014-01-21	2020-10-13	Pfizer	Composições imunogénicas que compreendem antigénios de sacáridos capsulares conjugados e utilizações das mesmas
EP3244917B1 (en)	2015-01-15	2023-04-19	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines
CA2983708C (en)	2015-04-28	2023-09-19	Biological E Limited	Method for separation of protein and other impurities from microbial capsular polysaccharides
TWI807252B (zh)	2015-05-04	2023-07-01	美商輝瑞股份有限公司	Ｂ型鏈球菌多醣-蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途
KR102225282B1 (ko)	2015-07-21	2021-03-10	화이자 인코포레이티드	접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
CA3005524C (en)	2015-11-20	2023-10-10	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines
TWI770044B (zh)	2016-08-05	2022-07-11	南韓商Ｓｋ生物科技股份有限公司	多價肺炎球菌多醣-蛋白質共軛物組成物(一)
SG11201900794PA (en)	2016-08-05	2019-02-27	Sanofi Pasteur Inc	Multivalent pneumococcal polysaccharide-protein conjugate composition
US10751402B2 (en)	2016-11-09	2020-08-25	Pfizer Inc.	Immunogenic compositions and uses thereof
MX2019007910A (es)	2016-12-30	2019-12-05	Sutrovax Inc	Conjugados de polipeptido-antigeno con aminoacidos no naturales.
US11951165B2 (en)	2016-12-30	2024-04-09	Vaxcyte, Inc.	Conjugated vaccine carrier proteins
MX392525B (es)	2017-01-20	2025-03-12	Pfizer	Composiciones inmunogenicas para su uso en vacunas neumococicas
KR20240169144A (ko)	2017-01-31	2024-12-02	머크 샤프 앤드 돔 엘엘씨	다당류-단백질 접합체 제조 방법
KR20190121330A (ko)	2017-02-24	2019-10-25	머크 샤프 앤드 돔 코포레이션	스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체의 면역원성의 증진
US10435433B2 (en)	2017-07-05	2019-10-08	Inventprise, Llc	Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
US10702596B2 (en)	2017-07-05	2020-07-07	Inventprise, Llc	Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
WO2019050813A1 (en)	2017-09-07	2019-03-14	Merck Sharp & Dohme Corp.	ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
US11389540B2 (en)	2017-09-07	2022-07-19	Merck Sharp & Dohme Llc	Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
BR112020011414B8 (pt)	2017-12-06	2023-01-31	Merck Sharp & Dohme	Composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae
BR112020014978A2 (pt)	2018-02-05	2020-12-22	Sanofi Pasteur, Inc.	Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
KR20230008923A (ko)	2018-02-05	2023-01-16	사노피 파스퇴르 인코포레이티드	다가 폐렴구균성 다당류-단백질 접합체 조성물
US20210252125A1 (en)	2018-04-30	2021-08-19	Merck Sharp & Dohme Corp.	Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
US12144855B2 (en)	2018-04-30	2024-11-19	Merck Sharp & Dohme Llc	Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
JP7397000B2 (ja)	2018-04-30	2023-12-12	メルク・シャープ・アンド・ドーム・エルエルシー	凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
DK3817775T3 (da)	2018-07-04	2024-09-16	Vaxcyte Inc	Forbedringer i immunogene konjugater
WO2020010016A1 (en)	2018-07-04	2020-01-09	Sutrovax, Inc.	Self-adjuvanted immunogenic conjugates
JP7585203B2 (ja)	2018-12-12	2024-11-18	ファイザー・インク	免疫原性多重ヘテロ抗原多糖－タンパク質コンジュゲートおよびその使用
EP3897705A2 (en)	2018-12-19	2021-10-27	Merck Sharp & Dohme Corp.	Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
CA3136278A1 (en)	2019-04-10	2020-10-15	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
PH12022550110A1 (en)	2019-07-31	2022-12-12	Sk Bioscience Co Ltd	Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
US12473379B2 (en) *	2019-09-06	2025-11-18	Serum Institute Of India Private Limited	Method for obtaining purified bacterial polysaccharides
KR20220072866A (ko) *	2019-10-01	2022-06-02	글리콤 에이/에스	발효액으로부터 중성 올리고사카라이드의 분리
MX2022010355A (es) *	2020-02-21	2022-09-21	Pfizer	Purificacion de sacaridos.
EP4150104A1 (en) *	2020-05-14	2023-03-22	Serum Institute Of India Private Limited	Methods for simultaneous fragmentation and purification of bacterial polysaccharides
CA3192786A1 (en)	2020-08-26	2022-03-03	Pfizer Inc.	Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
EP4232593A1 (en) *	2020-10-22	2023-08-30	Pfizer Inc.	Methods for purifying bacterial polysaccharides
CA3200602A1 (en)	2020-11-04	2022-05-12	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines
US20230405137A1 (en)	2020-11-10	2023-12-21	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2022234405A1 (en)	2021-05-03	2022-11-10	Pfizer Inc.	Vaccination against bacterial and betacoronavirus infections
WO2022234416A1 (en)	2021-05-03	2022-11-10	Pfizer Inc.	Vaccination against pneumoccocal and covid-19 infections
CA3221075A1 (en)	2021-05-28	2022-12-01	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
KR20230175284A (ko)	2021-05-28	2023-12-29	화이자 인코포레이티드	접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
WO2023135515A1 (en)	2022-01-13	2023-07-20	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024084397A1 (en)	2022-10-19	2024-04-25	Pfizer Inc.	Vaccination against pneumoccocal and covid-19 infections
WO2024110827A1 (en)	2022-11-21	2024-05-30	Pfizer Inc.	Methods for preparing conjugated capsular saccharide antigens and uses thereof
IL321062A (en)	2022-11-22	2025-07-01	Pfizer	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
KR20250113501A (ko)	2022-12-01	2025-07-25	화이자 인코포레이티드	폐렴구균 접합체 백신 제형
WO2024166008A1 (en)	2023-02-10	2024-08-15	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN121038808A (zh)	2023-03-30	2025-11-28	辉瑞公司	包含缀合的荚膜糖抗原的免疫原性组合物及其用途
PE20252779A1 (es)	2023-04-14	2025-12-22	Pfizer	Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y usos de estos
WO2024224266A1 (en)	2023-04-24	2024-10-31	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
EP4713008A2 (en)	2023-05-19	2026-03-25	GlaxoSmithKline Biologicals S.A.	Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection
TW202527906A (zh)	2023-09-14	2025-07-16	美商輝瑞股份有限公司	包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
WO2025133971A1 (en)	2023-12-23	2025-06-26	Pfizer Inc.	Improved methods for producing bacterial capsular saccharide glycoconjugates
WO2025186705A2 (en)	2024-03-06	2025-09-12	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2025219908A2 (en)	2024-04-19	2025-10-23	Pfizer Inc.	Media and fermentation methods for polysaccharide production in bacterial cell culture
WO2025219904A1 (en)	2024-04-19	2025-10-23	Pfizer Inc.	Improved methods for producing glycoconjugates by reductive amination in aprotic solvent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4413057A (en) *	1980-04-14	1983-11-01	Merck & Co., Inc.	Group B streptococcal capsular polysaccharides
CA2059692C (en) *	1991-01-28	2004-11-16	Peter J. Kniskern	Pneumoccoccal polysaccharide conjugate vaccine
JP2002539273A (ja) *	1999-03-19	2002-11-19	スミスクラインビーチャムバイオロジカルズソシエテアノニム	ワクチン
IL151772A0 (en) *	2000-03-16	2003-04-10	Philadelphia Children Hospital	Methods for producing pneumococcal capsular polysaccharide
GB0115176D0 (en) *	2001-06-20	2001-08-15	Chiron Spa	Capular polysaccharide solubilisation and combination vaccines
US20050220777A1 (en) *	2003-11-21	2005-10-06	Stefan Roos	Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae
DK3466982T3 (da) *	2005-04-08	2020-08-03	Wyeth Llc	Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation
CA2636983A1 (en) *	2006-01-13	2007-07-26	Baxter International Inc.	Method for purifying polysaccharides

2007
- 2007-10-09 KR KR1020097009585A patent/KR101467002B1/ko active Active
- 2007-10-09 MX MX2009003730A patent/MX2009003730A/es active IP Right Grant
- 2007-10-09 CN CN201210083999.1A patent/CN102648979B/zh active Active
- 2007-10-09 AT AT07843999T patent/ATE473289T1/de active
- 2007-10-09 CN CN2007800378009A patent/CN101522906B/zh active Active
- 2007-10-09 DE DE602007007642T patent/DE602007007642D1/de active Active
- 2007-10-09 BR BRPI0717834A patent/BRPI0717834B8/pt active IP Right Grant
- 2007-10-09 US US11/869,206 patent/US7659090B2/en active Active
- 2007-10-09 DK DK07843999.9T patent/DK2074221T3/da active
- 2007-10-09 RU RU2009112453/10A patent/RU2460539C2/ru active
- 2007-10-09 CA CA2665169A patent/CA2665169C/en active Active
- 2007-10-09 PT PT07843999T patent/PT2074221E/pt unknown
- 2007-10-09 BR BR122019021950A patent/BR122019021950B8/pt active IP Right Grant
- 2007-10-09 JP JP2009532526A patent/JP5260531B2/ja active Active
- 2007-10-09 WO PCT/US2007/080768 patent/WO2008045852A2/en not_active Ceased
- 2007-10-09 CL CL200702909A patent/CL2007002909A1/es unknown
- 2007-10-09 AU AU2007307800A patent/AU2007307800C1/en active Active
- 2007-10-09 ES ES07843999T patent/ES2346929T3/es active Active
2009
- 2009-03-24 IL IL197782A patent/IL197782A/en active IP Right Grant
- 2009-04-09 ZA ZA200902502A patent/ZA200902502B/xx unknown
2014
- 2014-07-31 IL IL233893A patent/IL233893A/en active IP Right Grant

Also Published As

Publication number	Publication date
CA2665169A1 (en)	2008-04-17
MX2009003730A (es)	2009-04-22
IL197782A0 (en)	2011-08-01
IL197782A (en)	2014-08-31
CN101522906B (zh)	2012-05-30
BRPI0717834B8 (pt)	2021-05-25
AU2007307800C1 (en)	2014-03-13
WO2008045852A3 (en)	2008-06-19
BR122019021950B1 (pt)	2021-01-05
US20080102498A1 (en)	2008-05-01
CN102648979B (zh)	2014-05-14
HK1174836A1 (en)	2013-06-21
IL233893A0 (en)	2014-09-30
BR122019021950B8 (pt)	2021-07-27
BRPI0717834A2 (pt)	2014-06-10
WO2008045852A2 (en)	2008-04-17
KR101467002B1 (ko)	2014-12-01
PT2074221E (pt)	2010-09-06
RU2009112453A (ru)	2010-11-20
RU2460539C2 (ru)	2012-09-10
KR20090071629A (ko)	2009-07-01
CN102648979A (zh)	2012-08-29
IL233893A (en)	2017-04-30
AU2007307800B2 (en)	2012-12-20
JP5260531B2 (ja)	2013-08-14
CA2665169C (en)	2017-02-21
CN101522906A (zh)	2009-09-02
US7659090B2 (en)	2010-02-09
ZA200902502B (en)	2010-03-31
CL2007002909A1 (es)	2008-04-18
AU2007307800A1 (en)	2008-04-17
ATE473289T1 (de)	2010-07-15
JP2010505963A (ja)	2010-02-25
DE602007007642D1 (de)	2010-08-19
BRPI0717834B1 (pt)	2020-05-19
ES2346929T3 (es)	2010-10-21

Publication	Publication Date	Title
IL233893A (en)	2017-04-30	Methods for separating Streptococcus pneumoniae type 3 polysaccharides
EA201070987A1 (ru)	2011-04-29	Очищенные гибридные белки иммуноглобулина и способы их очищения
MX2019005911A (es)	2019-07-08	Anticuerpos anti_cd137 novedosos y usos de estos.
MX2021003056A (es)	2021-05-27	Composiciones funcionales derivadas de frijol mungo.
ATE537188T1 (de)	2011-12-15	Serumalbuminbindende proteine
EP4512422A3 (en)	2025-05-21	Homogenous antibody populations
WO2007011363A3 (en)	2007-07-05	Binding domain fusion proteins
GEP20217222B (en)	2021-02-10	Antibodies specific for hyperphosphorylated tau and methods of use thereof
MX348154B (es)	2017-05-30	Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
MX2010002269A (es)	2010-03-25	Composiciones y metodos que comprenden proteinas de union para adalimumab.
WO2010017103A3 (en)	2010-04-01	Fully human anti-human nkg2d monoclonal antibodies
WO2010033279A3 (en)	2010-06-17	Antibodies with altered binding to fcrn and methods of using same
WO2007098201A3 (en)	2009-04-16	Shiga toxoid chimeric proteins
Saxena et al.	2007	Three phase partitioning as a novel method for purification of ragi (Eleusine coracana) bifunctional amylase/protease inhibitor
DK2086356T3 (da)	2010-10-04	Fremgangsmåde til opnåelse af knoldfrugtprotein-fraktioner med middelmolekylvægt, knoldfrugtprotein-fraktion og anvendelse af den samme
MX2019000903A (es)	2019-05-15	Metodos para purificar proteinas que contienen fc.
WO2010142551A8 (en)	2011-04-21	Amino acid sequences directed against receptors to cytokines belonging to the il-17 family
MX2022016322A (es)	2023-01-24	Anticuerpos de alta afinidad dirigidos a tau fosforilada en la serina 413.
WO2018132821A3 (en)	2018-08-23	Elastomeric proteins
WO2009043922A3 (en)	2009-08-27	Extracellular targets for alzheimer's disease
WO2008033556A3 (en)	2008-10-16	High pressure treatment of proteins for reduced immunogenicity
WO2009155102A3 (en)	2010-03-04	Method for derivatization of proteins using hydrostatic pressure
EA200970332A1 (ru)	2009-10-30	Новые антигены и антитела, ассоциированные с аденокарциномой панкреатического протока
TW200506057A (en)	2005-02-16	Transient production of pharmaceutically important proteins in plants
MX380226B (es)	2025-03-12	Proceso para preparar apolipoproteina a-i (apo a-i).